EA
LOXO

Emerald Acquisition’s Loxo Oncology, Inc LOXO Stock Holding History

Emerald Acquisition’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$839K Sell
32,042
-7,570
-19% -$198K ﹤0.01% 2216
2016
Q2 		$918K Buy
+39,612
New +$986K ﹤0.01% 2214

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Acquisition's LOXO Position: Q3 2016 in Review

Emerald Acquisition reduced its Loxo Oncology, Inc (LOXO) stake by 19% in Q3 2016, selling an estimated $198K and leaving 32,042 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Emerald Acquisition first reported a position in LOXO in Q2 2016 and has held it in 2 quarters since. The position peaked at $918K in Q2 2016. 72 funds tracked by Wall St. Rank hold LOXO as of Q3 2016.

  • Emerald Acquisition held 32,042 shares of Loxo Oncology, Inc worth $839K as of Q3 2016.
  • Emerald Acquisition sold 7,570 Loxo Oncology, Inc shares in Q3 2016, an estimated $198K.
  • Loxo Oncology, Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2216 holding.
  • Emerald Acquisition first reported a position in Loxo Oncology, Inc in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Loxo Oncology, Inc position peaked at $918K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.